Trattamento clinico di base editing ad alta precisione per l'anemia falciforme: CS-101 di CorrectSequence Therapeutics ottiene risultati promettenti sul primo paziente

CorrectSequence Therapeutics Bahrain Iran Iraq Jordan Kuwait Lebanon Oman Palestine Qatar Saudi Arabia Syria United Arab Emirates Yemen China

View original content:https://www.prnewswire.com/news-releases/trattamento-clinico-di-base-editing-ad-alta-precisione-per-lanemia-falciforme-cs-101-di-correctsequence-therapeutics-ottiene-risultati-promettenti-sul-primo-paziente-302540911.html